2.22 +0.00 (0.00%)
ANDS
Stock Details
Last Trade:2.22 Change:+0.00 (0.00%) Prev Close:2.22 Open: 2.19 Days Range:2.15 – 2.32 52 Week Range: 1.44 - 8.43 Volume:502057 P/E: N/AEPS:-1.02
View AllRecent Alerts 02/10/10
Recent Alert on 01/22/10 at 7:40am
Anadys Pharma (ANDS) Completes ANA598 Dosing in Phase II in HCV Patients
Anadys Pharma (ANDS) Completes ANA598 Dosing in Phase II in HCV Patients
Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV... Read More
Recent Alert on 01/22/10 at 7:40am
Anadys Pharma (ANDS) Completes ANA598 Dosing in Phase II in HCV Patients
Anadys Pharma (ANDS) Completes ANA598 Dosing in Phase II in HCV Patients
Recent Alert on 12/17/09 at 1:17pm
Unusual 11 Mid-Day Movers 12/17: FUN, WGO, WNI, SNSS, MPG Higher; EFJI, GEOY, NANO, ANDS Lower
Unusual 11 Mid-Day Movers 12/17: FUN, WGO, WNI, SNSS, MPG Higher; EFJI, GEOY, NANO, ANDS Lower
Recent Alert on 12/17/09 at 8:01am
Anadys Pharma (ANDS) Announces Preliminary ANA598 200 mg BID Phase II Results
Anadys Pharma (ANDS) Announces Preliminary ANA598 200 mg BID Phase II Results
Recent Alert on 12/17/09 at 8:01am
Anadys Pharma (ANDS) Announces Preliminary ANA598 200 mg BID Phase II Results
Anadys Pharma (ANDS) Announces Preliminary ANA598 200 mg BID Phase II Results
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available